Lisata Therapeutics annual operating margin
2010
2011
2012
2013
2014
2015
2016
2024
2025
Lisata Therapeutics Operating Margin Growth & History (LSTA)
Lisata Therapeutics's operating margin was −10,711.18% for fiscal 2025.
View full Lisata Therapeutics company overviewLisata Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −10,711.18% | −8470.28 pp |
| 2024 | 2024-12-31 | −2,240.90% | — |
| 2016 | 2016-12-31 | −83.61% | +422.66 pp |
| 2015 | 2015-12-31 | −506.28% | −184.40 pp |
| 2014 | 2014-12-31 | −321.88% | −70.94 pp |
| 2013 | 2013-12-31 | −250.94% | −38.90 pp |
| 2012 | 2012-12-31 | −212.04% | +126.31 pp |
| 2011 | 2011-12-31 | −338.35% | −311.31 pp |
| 2010 | 2010-12-31 | −27.04% | — |
Lisata Therapeutics quarterly operating margin
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q4.24
Q2.25
Q4.25
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2025 | 2025-12-31 | −3,080.00% | −2585.10 pp |
| Q2 2025 | 2025-06-30 | −6,954.29% | — |
| Q4 2024 | 2024-12-31 | −494.90% | — |
| Q1 2017 | 2017-03-31 | −81.19% | +66.66 pp |
| Q4 2016 | 2016-12-31 | −52.03% | +737.77 pp |
| Q3 2016 | 2016-09-30 | −61.47% | +114.86 pp |
| Q2 2016 | 2016-06-30 | −89.22% | +348.29 pp |
| Q1 2016 | 2016-03-31 | −147.85% | +422.33 pp |
| Q4 2015 | 2015-12-31 | −789.81% | −495.02 pp |
| Q3 2015 | 2015-09-30 | −176.33% | +218.49 pp |
| Q2 2015 | 2015-06-30 | −437.52% | −160.61 pp |
| Q1 2015 | 2015-03-31 | −570.19% | −237.37 pp |
| Q4 2014 | 2014-12-31 | −294.78% | −37.44 pp |
| Q3 2014 | 2014-09-30 | −394.82% | −143.59 pp |
| Q2 2014 | 2014-06-30 | −276.91% | −89.48 pp |
| Q1 2014 | 2014-03-31 | −332.81% | +17.08 pp |
| Q4 2013 | 2013-12-31 | −257.35% | +31.37 pp |
| Q3 2013 | 2013-09-30 | −251.22% | −68.79 pp |
| Q2 2013 | 2013-06-30 | −187.43% | +14.56 pp |
| Q1 2013 | 2013-03-31 | −349.90% | −149.98 pp |
| Q4 2012 | 2012-12-31 | −288.71% | — |
| Q3 2012 | 2012-09-30 | −182.43% | +149.69 pp |
| Q2 2012 | 2012-06-30 | −201.99% | +252.13 pp |
| Q1 2012 | 2012-03-31 | −199.92% | −163.80 pp |
| Q3 2011 | 2011-09-30 | −332.13% | −297.26 pp |
| Q2 2011 | 2011-06-30 | −454.13% | −436.08 pp |
| Q1 2011 | 2011-03-31 | −36.12% | — |
| Q3 2010 | 2010-09-30 | −34.86% | — |
| Q2 2010 | 2010-06-30 | −18.05% | — |
Lisata Therapeutics operating margin trends
Between the periods ended 2010-12-31 and 2025-12-31, Lisata Therapeutics's operating margin decreased from −27.04% to −10,711.18%, a change of −10684.14 percentage points. The latest reported quarter, Q4 2025, shows −3,080.00%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lisata Therapeutics source filings ↗Community posts
Lisata acquires Marea and signs $225 million financing agreement
Lisata ($LSTA) Therapeutics acquired Marea Therapeutics in a stock-for-stock transaction and signed a concurrent agreement for approximately $225 million in gross private-placement proceeds. The financing involves non-voting convertible pre ...
